Pacific Mercantile Bank Increases Financing for Marque Medical to $3.9 Million
Nov 18, 2016 13:00 pm UTC| Business
COSTA MESA, Calif., Nov. 18, 2016 -- Pacific Mercantile Bank (“the Bank”), the wholly owned subsidiary of Pacific Mercantile Bancorp (NASDAQ:PMBC), today announced that it has increased the financing for Marque Medical...
Altimmune to Present at the 28th Annual Piper Jaffray Healthcare Conference
Nov 18, 2016 13:00 pm UTC| Business
GAITHERSBURG, Md., Nov. 18, 2016 -- Altimmune, Inc., a clinical stage immunotherapeutic company, today announced that management will be presenting at the 28th Annual Piper Jaffray Healthcare Conference to be held...
Mobifalcon Releases New Local Shopping App for iOS
Nov 18, 2016 13:00 pm UTC| Business
Dallas, Nov. 18, 2016 -- Mobifalcon Inc., a Dallas based mobile technology development startup has announced that their local shopping App, moblMall is now available on the Apple App Store just in time for the upcoming...
Global Defoamers Market Set to reach USD 3.6 Billion by 2021: Zion Market Research
Nov 18, 2016 12:13 pm UTC| Business
Sarasota, FL, Nov. 18, 2016 -- Zion Research has published a new report titled “Defoamers Market (Water Based, Silicone Based, Oil Based, and Others) Paper Pulp, Paints Coatings, Water Treatment, Food Beverages, and...
Nov 18, 2016 12:01 pm UTC| Business
- Durable Stable Disease Observed for Patients with Non-enhancing Low Grade Glioma and Chondrosarcoma Patients; 42% of Glioma Patients Still on Treatment- - AG-120 Well-tolerated in Pre-Treated Populations - -Potential...
Insys Therapeutics, Inc. to Present at Piper Jaffray 28th Annual Healthcare Conference
Nov 18, 2016 12:00 pm UTC| Business
PHOENIX, Nov. 18, 2016 -- Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that Darryl Baker, Chief Financial Officer, and Santosh Vetticaden, MD, PhD, Senior Vice President and Chief...
Apricus Biosciences Provides Update on Vitaros NDA Following Receipt of FDA Feedback
Nov 18, 2016 12:00 pm UTC| Business
SAN DIEGO, Nov. 18, 2016 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has received feedback in response to...
FxWirePro- Major Economic events for the day
Rachel Reeves Faces Potential £25 Billion Tax Increase in Upcoming Budget to Support Public Services